Pharmafile - Medical Communications News
The US National Institutes of Health (NIH) said it is launching a clinical trial testing hydroxychloroquine in combination with azithromycin in...
The NHS’s first data breakdown of underlying health conditions in COVID-19 fatalities has shown that 1 in 4 deaths in hospitals occurred in diabetics.
The news this week continues to be dominated by COVID-19 vaccines and treatments, with the NIAID announcing the launch of a second remdesivir trial...
A research team at the Institut Pasteur Korea have identified a drug that appears to be more effective in treating COVID-19 than Gilead’s remdesivir.
The NHS has set out plans to step up its non-COVID-19 services over the next six weeks.
Bristol Myers Squibb and Acceleron Pharma’s Reblozyl (luspatercept) has secured a positivr opinion from the European Medicines Agency’s...
The coronavirus pandemic is likely to last as long as two years and will not be properly controlled until two-thirds of the world’s populations have...
The European Medicines Agency’s Committee for Medicinal Products for Human Use has given its recommendation for the approval of Kalydeco for the...
The search for a COVID-19 treatment has ramped up this week, with two new studies detailing the efficacy of Gilead’s antiviral therapy remdesivir in...
COVID-19 continues to dominate the news cycle as we all try to maintain business as usual under the shadow of the pandemic. Just about every area of...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches
